Ofer Merimsky
Impact in
- Oncology top 2%
- Vascular Tumors and Angiosarcomas
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Sarcoma Diagnosis and Treatment 60
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 11
- Oncology 95
- Vascular Tumors and Angiosarcomas 22
- Cancer Treatment and Pharmacology 13
- Cancer Diagnosis and Treatment 12
- Co-authors
- Samario Chaitchik (49 shared papers)Moshe Inbar (51 shared papers)Yehuda Kollender (37 shared papers)Isaac Meller (35 shared papers)Jacob Bickels (27 shared papers)Josephine Issakov (19 shared papers)Ronit Sagi‐Eisenberg (7 shared papers)Gideon Flusser (19 shared papers)
- Journals
- Oncology Reports (11 papers)Journal of Clinical Oncology (10 papers)Anti-Cancer Drugs (8 papers)Cancer Chemotherapy and Pharmacology (5 papers)Sarcoma (5 papers)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Ofer Merimsky
184 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 116
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Rheumatology 402
- Cancer Research 259
- Pathology and Forensic Medicine 288
Countries citing papers authored by Ofer Merimsky
This map shows the geographic impact of Ofer Merimsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Merimsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Merimsky more than expected).
Fields of papers citing papers by Ofer Merimsky
This network shows the impact of papers produced by Ofer Merimsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Merimsky. The network helps show where Ofer Merimsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Ofer Merimsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 113 | |
| 2 | 2000 | 86 | |
| 3 | 2004 | 82 | |
| 4 | 2000 | 81 | |
| 5 | 2017 | 80 | |
| 6 | Computed tomography-guided core needle biopsy for bone and soft tissue tumors. | 2003 | 74 |
| 7 | 2011 | 70 | |
| 8 | 1994 | 59 | |
| 9 | 2012 | 47 | |
| 10 | 2003 | 45 | |
| 11 | 1992 | 42 | |
| 12 | 1999 | 42 | |
| 13 | 2001 | 41 | |
| 14 | 2021 | 41 | |
| 15 | 2004 | 40 | |
| 16 | 2008 | 40 | |
| 17 | 1997 | 40 | |
| 18 | 1990 | 36 | |
| 19 | 1999 | 36 | |
| 20 | 2000 | 35 |
About Ofer Merimsky
Ofer Merimsky is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Rheumatology, having authored 188 papers that have together received 2.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (60 papers), Vascular Tumors and Angiosarcomas (22 papers), Lung Cancer Treatments and Mutations (18 papers), Bone Tumor Diagnosis and Treatments (16 papers), Cancer Treatment and Pharmacology (13 papers), Cancer Diagnosis and Treatment (12 papers), Management of metastatic bone disease (12 papers) and Lung Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations), Rheumatology (402 citations), Cancer Research (259 citations) and Pathology and Forensic Medicine (288 citations). Ofer Merimsky has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Samario Chaitchik, Moshe Inbar, Yehuda Kollender, Isaac Meller, Jacob Bickels, Josephine Issakov, Ronit Sagi‐Eisenberg, Gideon Flusser, Pnina Fishman and Sivan Shamai. Their work appears in journals such as Oncology Reports, Journal of Clinical Oncology, Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.